Menovex

Based in Shenzhen, China and founded in 2019, Menovex Medical Technology (Shenzhen) Co. , Ltd. , trading under the name Menovex and formerly known as MIL Medical Technology (Shenzhen) Co. , Ltd.

, provides laser medical system solutions and auxiliary products for the dental, urology, dermatology, and vascular sectors. The company's founding team consists of multiple researchers with doctorates from Tsinghua University. In June 2026, Menovex closed a round of series B funding led by Shenzhen Capital Real Estate Fund with participation from Shenzhen Nanshan Huirong Investment, Shenzhen Xiaohe Investment, Shenzhen HTI and Shunbai Fund. Menovex provides laser medical and aesthetic technology solution and related service.

The company's product includes laser treatment equipment for oral and ENT (Ear, Nose, and Throat) diseases, visible light band air-cooled solid-state laser, and mid-infrared tunable air-cooled solid-state laser. The business of the company includes development, production and sales dental, medical beauty and urinary laser treatment equipment. The company's revenue is generated by providing laser medical devices. The company will use the series B funding for the registration, clinical trials, and commercialization of multidisciplinary laser medical devices, continuous iterative research and development of core laser technologies, and the expansion of global market channels.